Condition: Myelodysplastic Syndrome · Anemia · Sponsor: Takeda
The main aim of this study is to assess how elritercept works in lowering the need for RBC (red blood cell) transfusions and how safe elritercept is when compared with epoetin alfa. Other aims are to learn if elritercept improves tiredness as reported by participants without needing RBC transfusion compared with epoetin alfa, the RBC transfusion burden and quality of life compared with epoetin alfa. The study also aims to find out the extent of the immune response to elritercept. The study will also check on the medical problems (safety) of elritercept.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Not Yet Recruiting |
| City of Hope - Comprehensive Cancer Center (CCC) | Duarte, California, United States | Not Yet Recruiting |
| Providence Medical Group | Santa Rosa, California, United States | Not Yet Recruiting |
| Cancer & Blood Research Center | Whittier, California, United States | Not Yet Recruiting |
| University of Miami | Miami, Florida, United States | Not Yet Recruiting |
| BRCR Medical Center Inc | Tamarac, Florida, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Orchard Healthcare Research Inc. (OHR) - Skokie | Skokie, Illinois, United States | Recruiting |
| Norton Cancer Institute | Louisville, Kentucky, United States | Not Yet Recruiting |
| American Oncology Partners P.A. MidAmerica Cancer Care | Kansas City, Missouri, United States | Recruiting |
| Albert Einstein College - Montefiore | The Bronx, New York, United States | Not Yet Recruiting |
+ 144 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07422480